IMMUNOMEDICS INC
10-K, EX-23, 2000-09-28
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IMMUNOMEDICS INC, 10-K, 2000-09-28
Next: IMMUNOMEDICS INC, 10-K, EX-27, 2000-09-28




                                  EXHIBIT 23.1

                          INDEPENDENT AUDITORS' CONSENT
                         -------------------------------

The Board of Directors
Immunomedics, Inc.:

We consent to  incorporation  by reference in the  registration  statements (No.
333-44501,  333-69975,  333-90665, 333-94415 and 333-31178) on Form S-3 and (No.
33-56844  and  33-16260) on Form S-8 of  Immunomedics,  Inc. of our report dated
August  15,  2000,  except as to the last  paragraph  of Note 9,  which is as of
September 19, 2000, relating to the consolidated balance sheets of Immunomedics,
Inc. and subsidiaries as of June 30, 2000 and 1999, and the related consolidated
statements  of  operations  and  comprehensive  loss,  changes in  stockholders'
equity, and cash flows for each of the years in the three-year period ended June
30, 2000,  which report  appears in the June 30, 2000 annual report on Form 10-K
of Immunomedics, Inc.


                                                                        KPMG LLP

Short Hills, New Jersey
September 28, 2000

                                       54
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission